longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BioStem Tech

BSEM

4.1406.70% ( +0.260 )
Closed: Sep 25, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -2.61, within the reasonable range, cheaper than 66.67% of the time in the past 1 years, and the industry ranks 135/256, the industry Median -1.39.

-2.61xP/E
$4.14Stock price
$-1.59Earnings per share
-2.61xP/E
Stock price$4.14Earnings per share$-1.59

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-2.43x
Typical range
-2.72x–-2.23x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
TAKUSTakeda Pharmaceutical Company
-57.06x149.86%$59.58B
BAYRYUSBayer
-27.89x--$56.27B
BAYZFUSBayer Aktiengesellschaft
-27.59x--$55.67B
VTRSUSViatris
-49.86x107.75%$20.48B
ELANUSElanco Animal Health
-56.01x129.36%$11.15B
VREOFUSVIREO GROWTH INC
-159.36x--$10.70B
AXSMUSAxsome Therap
-53.32x26.93%$10.22B
CURLFUSCuraleaf Holdings, Inc.
-162.87x--$8.47B
BLTEUSBelite Bio
-65.83x29.87%$6.74B
MANEUSVeraDermics
-46.70x97.44%$4.87B
DFTXUSDefinium Therapeutics
-13.74x53.61%$4.86B
EWTXUSEdgewise Therapeutics
-21.66x137.29%$4.27B
AMLXUSAmylyx Pharmaceuticals
-24.34x1.76%$3.70B
TARSUSTarsus Pharmaceuticals
-71.47x34.17%$3.32B
ELVNUSEnliven Therapeutics
-30.95x1.17%$3.28B
RGCUSRegencell Bioscience
-433.71x--$3.06B
MBXUSMBX Biosciences
-24.77x30.54%$2.58B
GPCRUSStructure Therapeutics
-11.92x102.05%$2.56B
SUPNUSSupernus Pharma
-22.57x70.59%$2.48B
TRLVUSTrulieve Cannabis
-4.97x198.82%$2.35B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.